No More Tire Kicking: Chris Amstutz Shares Views on PAT’s Expansion
15 May 2012
There's been a shift in the industry in the past 18 months, says Emerson's life sciences expert, from experimentation to broad implementation.
Featured Stories
Design of Experiments Helps Boost Key Intermediate Yield by 18%
14 May 2012
How recent design of experiments work at Codexis Labs in Singapore led to an 18% increase in yield of a key intermediate.
Posted in Resources0 Comments
Welcome ICH Q11
11 May 2012
The final document, pertaining to the development and manufacture of drug substance, is now available and moves Q11 into its implementation phase.
Posted in QbD News, Resources0 Comments
Framing a QbD Design Space with Tolerance Intervals
10 May 2012
Via the response surface method, more conservative tolerance intervals can be imposed, and a more robust design space achieved. Mark Anderson of Stat-Ease demonstrates how.
Posted in Expert Insights, Resources0 Comments
Can QbD Get Its Definitions Straight?
08 May 2012
After all these years, wonders Emil Ciurczak, why is there still so little agreement on basic terminology?
Posted in Expert Insights, Opinion Editorial0 Comments
Steven Burrill: Can Pharma Turn the Oceanliner Around?
26 April 2012
To survive, the biotech guru says, Big Pharma must ignore the “gravel in the road” and continue driving towards personalized medicine.
Posted in Expert Insights, Readers' Choice1 Comment
Currently Playing...
More PAT Video from Pfizer UK: Using NIR to Monitor Tray Drying
Added on 13 December 2010
View More Videos
-
muscopatt: I certainly hope no one paid to hear burrill on th...
-
zasmine: It is a very state indeed when the regulator doesn...
-
Ali Afnan: Many thanks for your comment. I agree with you in...
-
aajax: Has anyone done a good analysis of the cost to the...
-
AIChE
Ali Afnan
analytical methods
Bikash Chatterjee
biopharmaceutical QbD
bioprocess control
CDER
continuous manufacturing
design of experiments
design space
drug development
DynoChem
Eli Lilly
Emerson Process Management
Emil Ciurczak
fda
Gawayne Mahboubian-Jones
Genentech
Girish Malhotra
GSK
guidance documents
helen winkle
ICH
ICH Q8
ICH Q10
IFPAC
ISPE
Joe Hannon
Lean Six Sigma
LinkedIn
Merck
modeling
Moheb Nasr
Novartis
operational excellence
PAT
PDA
Pfizer
pharmacutical quality
process understanding
process validation
qbd
risk management
time to market
Toyota
Stay up to date
- Subscribe to the RSS feed
- Subscribe to PharmaQbD by Email